Cancer News and Research

Latest Cancer News and Research

Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk

An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up suggested durable immune memory with encouraging relapse-free outcomes, though controlled trials are needed to confirm clinical benefit.

19 Feb 2026

Cyborg transplants may advance cell-based therapies for diabetes

A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes.

19 Feb 2026

New guidelines outline comprehensive care for acute pulmonary embolism

Early detection and prompt treatment of acute pulmonary embolism (PE), a sudden and potentially life-threatening blood clot that blocks arteries in the lungs, is critical.

19 Feb 2026

Study reveals long-term health risks after chemotherapy for testicular cancer

A large, multi-center study recently published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy regimens used to treat testicular cancer, highlighting differences in renal function, cardiovascular risk, and the overall burden of chronic health conditions among survivors.

19 Feb 2026

Blood test shows promise in forecasting outcomes for germ cell tumors

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima Center investigated this question together with experts from Italy and Slovakia.

19 Feb 2026

High-cost rare disease drugs challenge Norwegian health priorities

New medical developments make it possible to treat an increasing number of severe and rare diseases with novel, high-cost pharmaceuticals.

19 Feb 2026

Single blood test predicts onset of Alzheimer’s symptoms years ahead

Researchers at Washington University School of Medicine in St. Louis have developed a method to predict when someone is likely to develop symptoms of Alzheimer's disease using a single blood test.

19 Feb 2026

An Arm and a Leg: Personal finance guru faces down an insurance denial

Less than 36 hours before his wife was scheduled to undergo major surgery, New York Times personal finance columnist Ron Lieber got an unwelcome letter from his family's insurance plan: It was denying prior authorization for the procedure.

19 Feb 2026

Low-field MRI could offer an alternative to existing breast cancer screening methods

Mass General Brigham's evaluation of low-field MRI performance lays potential groundwork for this technology to be a lower-cost, accessible option for breast imaging.

19 Feb 2026

Modern farming waste carries emerging contaminants that threaten ecosystems and health

A new scientific review highlights a growing environmental challenge linked to modern food production. Researchers report that waste from livestock and aquaculture operations now contains a complex mix of emerging contaminants that can spread through ecosystems and ultimately affect human health.

18 Feb 2026

Hormone replacement therapy shows no rise in overall mortality

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published by The BMJ today.

18 Feb 2026

Breast screening associated with better ten-year survival in stage IV cancer

Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis.

18 Feb 2026

How GLP-1 drugs affect the body beyond weight loss and glucose control

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.

18 Feb 2026